Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JY09 in Type 2 Diabetes Mellitus – Phase II Multiple-dose PK/PD Study
CTR20192166Phase 2Completed
- Sponsor
- Orient Gene
- Start
- Oct 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of JY-09 in type 2 diabetes mellitus (T2DM), sponsored by Orient Gene. Started Oct 2019; status: completed.
02
Drugs
JY-09
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192166.